Loading...
OTCM
CHHE
Market cap13mUSD
Jul 02, Last price  
0.20USD
IPO
-19.96%
Name

China Health Industries Holdings Inc

Chart & Performance

D1W1MN
P/E
P/S
117.54
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-55.72%
Revenues
112k
+41,689.89%
747,064842,139010,967,82843,105,97262,779,97858,935,5707,727,0409,709,09910,226,0527,816,5016,371,5526,554,9399,275,3869,931,8876,492,720267111,579
Net income
-409k
L+15.49%
-331,858-165,550-34,8982,824,45413,254,17117,673,99514,475,406-552,923-658,4672,561159,6021,311,827-316,8273,307,0393,550,6101,291,122-353,950-408,772
CFO
-42m
L
-205,505-71,729-91,4137,051,4809,515,6219,344,47320,892,290-10,489,376-1,353,1652,142,1401,888,4141,075,0202,989,3865,115,3852,404,9785,556,6942,115,726-42,272,498

Profile

China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. It offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, and hemp frozen age nourishing creams. The company also provides health supplements, including Sailuozhi soft capsule, which is made from frog oil, soybean isoflavone, procyanidine, and vitamin E for freckle removal and skin moisture supplements under the QunLe brand; and propolis and black ant capsule that is made from propolis, black ant, acanthopanax, and astragalus root under the Kindlink brand. In addition, it offers health products for acne removal, relieving eyestrain, enhancing bone density, enhancing memory, enhancing nutritional anemia and chloasma, relaxing bowels and promoting the discharge of lead, enhancing immunity and relieving physical fatigue, and dispelling chloasma, as well as iron and multivitamin, and mineral supplements. Further, the company manufactures and sells various types of medical drugs. It primarily sells its products through sales agents. China Health Industries Holdings, Inc. is based in Harbin City, the People's Republic of China.
IPO date
Dec 01, 2004
Employees
45
Domiciled in
CN
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
112
41,689.89%
Cost of revenue
111
Unusual Expense (Income)
NOPBT
220
NOPBT Margin
0.20%
Operating Taxes
Tax Rate
NOPAT
220
Net income
(409)
15.49%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
5,154
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
5,107
Cash flow
Cash from operating activities
(42,272)
CAPEX
Cash from investing activities
Cash from financing activities
FCF
(39,652)
Balance
Cash
47
Long term investments
Excess cash
42
Stockholders' equity
38,588
Invested Capital
44,222
ROIC
0.00%
ROCE
0.00%
EV
Common stock shares outstanding
65,540
Price
Market cap
EV
EBITDA
687
EV/EBITDA
Interest
Interest/NOPBT